(Q56945244)

English

Comparison of peak serum C-reactive protein and hydroxybutyrate dehydrogenase levels in patients with acute myocardial infarction treated with alteplase and streptokinase

scientific article published on 01 October 1997

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9352981%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Comparison of peak serum C-reactive protein and hydroxybutyrate dehydrogenase levels in patients with acute myocardial infarction treated with alteplase and streptokinase (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9352981%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

myocardial infarction

1 reference

based on heuristic

inferred from title

acute myocardial infarction

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9352981%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

author name string

K Pietilä

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9352981%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

W T Hermens

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9352981%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

A Harmoinen

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9352981%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

T Baardman

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9352981%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

A Pasternack

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9352981%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

M L Simoons

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9352981%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

language of work or name

0 references

publication date

1 October 1997

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9352981%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

American Journal of Cardiology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9352981%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

80

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9352981%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9352981%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1075-1077

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9352981%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

C-reactive protein fifty years on

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900606-1

7 January 2021

Intravenous streptokinase treatment and serum C-reactive protein in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900606-1

7 January 2021

Acute phase reaction, infarct size and in-hospital morbidity in myocardial infarction patients treated with streptokinase or recombinant tissue type plasminogen activator

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900606-1

7 January 2021

Serum C-reactive protein and infarct size in myocardial infarct patients with a closed versus an open infarct-related coronary artery after thrombolytic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900606-1

7 January 2021

Serum C-reactive protein concentration in acute myocardial infarction and its relationship to mortality during 24 months of follow-up in patients under thrombolytic treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900606-1

7 January 2021

Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900606-1

7 January 2021

Differential effects of tissue plasminogen activator and streptokinase on infarct size and on rate of enzyme release: influence of early infarct related artery patency. The GUSTO Enzyme Substudy

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900606-1

7 January 2021

The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900606-1

7 January 2021

An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900606-1

7 January 2021

Assessment of myocardial damage in patients with acute myocardial infarction by serial measurement of serum alpha-hydroxybutyrate dehydrogenase levels.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900606-1

7 January 2021

Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. GUSTO-I Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900606-1

7 January 2021

Benefit of thrombolytic therapy is sustained throughout five years and is related to TIMI perfusion grade 3 but not grade 2 flow at discharge. The European Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900606-1

7 January 2021

Identifiers

10.1016/S0002-9149(97)00606-1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9352981%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9352981%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q56945244&oldid=2107387764"